Avacta Group Plc

Stocks

Market Closed - London S.E. Other stock markets 16:35:19 14/07/2026 BST			5-day change	1st Jan Change
69.00 ^GBX	+0.73%		-2.13%	+18.97%

07-09	Avacta appoints "seasoned" new deputy chair	AN
07-09	Avacta Group Settles Accelerated Payment Under Convertible Bond	MT

Published on 05/25/2026 at 04:48 pm BST - Modified on 05/26/2026 at 01:47 am BST

S&P Capital IQ

Presenter Speech
Christina Coughlin (Executives)

Welcome to Science Day 2026. We're happy to have you here. I'd like to start by introducing the agenda. There will be 6 separate talks by the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

07-09	Avacta appoints "seasoned" new deputy chair	AN
07-09	Avacta Group Settles Accelerated Payment Under Convertible Bond	MT
07-08	Avacta Therapeutics Names Nonexecutive Deputy Chairman	MT
07-08	Avacta Group plc Announces Appointment of Patrick Vink as Non-Executive Deputy Chairman and Senior Independent Director	CI
06-25	EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities	AN
06-25	Avacta Therapeutics Reaches Study Design Terms With US FDA for Salivary Gland Cancer Therapy	MT
06-25	Avacta Therapeutics Announces U.S. FDA Agreement on Pivotal Trial Design for AVA6000 in Patients with Salivary Gland Cancer	CI
06-22	Avacta hails "strong progress" in first half of 2026	AN
06-05	Avacta Group raises GBP9 million for bond repayments	AN
06-05	Avacta Therapeutics Raises GBP9 Million from Share Issue	MT
06-01	Avacta Therapeutics Presents Updated Clinical Data for Ava6000 in Salivary Gland Cancers At Asco 2026	CI
05-29	EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value	AN
05-29	Avacta Group plc Announces Board Changes	CI
05-29	Avacta Therapeutics Names Chairman Designate	MT
05-28	Avacta Group Plc Auditor Raises 'Going Concern' Doubt	CI